Recombinant vaccines against tuberculosis challenge in normal as we ll as transgenic, HLADR-expressing, IA-deficient mice

Project Information

Grant agreement ID: IC15980307

Project closed

Start date 1 November 1998

End date 31 October 2001

Funded under

• Specific research, technological development and demonstration programme in the field of cooperation with third countries and international organizations, 1994-1998

Total cost No data

EU contribution No data

Coordinated by

RUSSIAN ACADEMY OF MEDICAL SCIENCES - CENTRAL INSTITUTE FOR SCIENTIFIC RESEARCH IN TUBERCULOSIS
Russia

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

• medical and health sciences › clinical medicine › pneumology › tuberculosis
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

You need to log in or register to use this function

Programme(s)

• FP4-INCO - Specific research, technological development and demonstration programme in the field of cooperation with third countries and international organizations, 1994-1998

Topic(s)

• 01021502 - Advanced diagnostics and prognostic in epidemiology

Call for proposal

Data not available

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

RUSSIAN ACADEMY OF MEDICAL SCIENCES - CENTRAL INSTITUTE FOR SCIENTIFIC RESEARCH IN TUBERCULOSIS

• EU contribution: No data
• Address: 2,Yauza Alley 2 ; 107564 MOSCOW ; Russia
• Total cost: No data

Participants (2)

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

United Kingdom

• EU contribution: No data
• Address: Norfolk Place ICST at St. Mary's ; W2 1PG LONDON
• Total cost: No data

LEIDEN UNIVERSITY

Netherlands

• EU contribution: No data
• Address: 2,Albinusdreef 2 ; 2300 RC LEIDEN
• Total cost: No data